Tradipitant
DrugOral Capsule
NCT Number: NCT04327661
A multi-center, randomized, double-blind, placebo-controlled study to investigate the efficacy of tradipitant in subjects affected by motion sickness during travel
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Phase 3
Pacific Research Network, LLC, San Diego, California, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Oral Capsule
Oral Capsule
Time frame: 1 day
Prevention of vomiting measured by Vomiting Assessment (VA) score in tradipitant high dose. The VA is a 1-item questionnaire to objectively measure the incidence of emesis. Participants will indicate whether or not they have vomited. The Count of Participants indicates participants who vomited.
Vanda Pharmaceuticals
Industry
Motion Syros: A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness During Travel
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06587386
Motion Sickness, Pathological Conditions, Signs and Symptoms
Jiaxing, China
View Trial DetailsNCT04999449
Motion Sickness, Pathological Conditions, Signs and Symptoms
Lebanon, New Hampshire, United States
View Trial DetailsNCT06354309
Amblyopia, Brain Diseases
Shenyang, Liaoning, China
View Trial DetailsNCT03772340
Motion Sickness, Pathological Conditions, Signs and Symptoms
Santa Monica, California, United States
View Trial Details